文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

推动建立心脏淀粉样变性卓越中心:国际心脏肿瘤学会声明

Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.
PubMed 文献 · Heart · 2024-05-23

国际心脏肿瘤学会发布声明,针对转甲状腺素蛋白和轻链淀粉样变性诊疗复杂性,提出建立卓越中心的必要性。通过多学科国际专家小组问卷调查,识别高效临床照护所需核心要素,制定机构可被认定为卓越中心的通用标准,以标准化期望和标准确保最高质量临床照护与社区教育。

要点

  • 淀粉样变性患病率上升,归因于认知提高、诊断路径演进及有效治疗选择。
  • 卓越中心认定可认可领先机构、建立诊疗期望并促进合作研究。
  • 标准化卓越中心期望和标准对确保高质量照护与社区教育至关重要。

核心结论

  • 建立心脏淀粉样变性卓越中心并标准化其期望和标准,有助于确保最高质量的临床照护和社区教育。

研究设计与样本

  • 国际心脏肿瘤学会声明,通过多学科国际专家小组合作开展问卷调查,识别卓越中心必要要素。

主要发现

  • 淀粉样变性患病率因认知提高、诊断路径演进及转甲状腺素蛋白和轻链淀粉样变性有效治疗选择而增加。
  • 卓越中心认定具有多重潜在益处,包括认可领先机构、建立诊疗期望和促进合作研究。

关键数值与推荐

  • 声明旨在识别高效临床照护所需必要要素,并制定机构可被认定为卓越中心的通用标准。

临床怎么用

  • 实践或机构可依据该通用标准被认定为心脏淀粉样变性卓越中心,以标准化诊疗期望。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of amyloidosis has been increasing, driven by a combination of improved awareness, evolution of diagnostic pathways, and effective treatment options for both transthyretin and light chain amyloidosis. Due to the complexity of amyloidosis, centralised expert providers with experience in delineating the nuances of confirmatory diagnosis and management may be beneficial. There are many potential benefits of a centre of excellence designation for the treatment of amyloidosis including recognition of institutions that have been leading the way for the optimal treatment of this condition, establishing the expectations for any centre who is engaging in the treatment of amyloidosis and developing cooperative groups to allow more effective research in this disease space. Standardising the expectations and criteria for these centres is essential for ensuring the highest quality of clinical care and community education. In order to define what components are necessary for an effective centre of excellence for the treatment of amyloidosis, we prepared a survey in cooperation with a multidisciplinary panel of amyloidosis experts representing an international consortium. The purpose of this position statement is to identify the essential elements necessary for highly effective clinical care and to develop a general standard with which practices or institutions could be recognised as a centre of excellence.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Cheng R, Kittleson MM, Wechalekar AD, et al. Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement. Heart. 2024. PMID: 38267197. doi:10.1136/heartjnl-2023-323502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。